Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Park Avenue Securities LLC

Park Avenue Securities LLC decreased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.8% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 14,940 shares of the medical equipment provider’s stock after selling 1,096 shares during the quarter. Park Avenue Securities LLC’s holdings in Intuitive Surgical were worth $7,340,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Ridgewood Investments LLC acquired a new stake in Intuitive Surgical during the second quarter valued at $26,000. Creekmur Asset Management LLC grew its position in shares of Intuitive Surgical by 200.0% during the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 42 shares during the period. LGT Financial Advisors LLC increased its stake in shares of Intuitive Surgical by 415.4% in the 2nd quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 54 shares in the last quarter. Delos Wealth Advisors LLC raised its holdings in Intuitive Surgical by 380.0% in the 1st quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 57 shares during the period. Finally, LRI Investments LLC purchased a new position in Intuitive Surgical during the first quarter worth approximately $30,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Intuitive Surgical

In other news, Director Craig H. Barratt sold 1,400 shares of the firm’s stock in a transaction on Tuesday, July 23rd. The stock was sold at an average price of $458.13, for a total transaction of $641,382.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other Intuitive Surgical news, Director Amy L. Ladd sold 450 shares of the business’s stock in a transaction on Friday, September 13th. The shares were sold at an average price of $490.28, for a total value of $220,626.00. Following the completion of the transaction, the director now owns 821 shares in the company, valued at $402,519.88. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Craig H. Barratt sold 1,400 shares of Intuitive Surgical stock in a transaction on Tuesday, July 23rd. The shares were sold at an average price of $458.13, for a total value of $641,382.00. The disclosure for this sale can be found here. Insiders have sold a total of 53,120 shares of company stock valued at $25,528,753 over the last quarter. 0.90% of the stock is owned by company insiders.

Analyst Ratings Changes

Several research analysts have recently weighed in on the company. Citigroup upped their target price on Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a research note on Thursday, August 22nd. Evercore ISI lifted their target price on shares of Intuitive Surgical from $410.00 to $475.00 and gave the company an “in-line” rating in a research report on Tuesday. JPMorgan Chase & Co. raised their price target on shares of Intuitive Surgical from $475.00 to $495.00 and gave the company an “overweight” rating in a research note on Friday, July 19th. Morgan Stanley increased their target price on Intuitive Surgical from $375.00 to $460.00 and gave the company an “equal weight” rating in a report on Monday, July 15th. Finally, Piper Sandler lifted their price target on Intuitive Surgical from $490.00 to $495.00 and gave the stock an “overweight” rating in a research note on Friday, July 19th. Six equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $449.70.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG traded up $2.32 during mid-day trading on Friday, reaching $481.95. 903,893 shares of the company’s stock were exchanged, compared to its average volume of 1,479,332. The company’s 50-day moving average is $476.55 and its 200-day moving average is $431.54. The firm has a market capitalization of $170.95 billion, a price-to-earnings ratio of 86.99, a PEG ratio of 5.39 and a beta of 1.39. Intuitive Surgical, Inc. has a 52-week low of $254.85 and a 52-week high of $496.48.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share for the quarter, topping the consensus estimate of $1.54 by $0.24. Intuitive Surgical had a net margin of 27.65% and a return on equity of 13.04%. The company had revenue of $2.01 billion during the quarter, compared to analyst estimates of $1.97 billion. During the same quarter last year, the firm posted $1.18 earnings per share. Intuitive Surgical’s revenue was up 14.5% compared to the same quarter last year. As a group, equities analysts predict that Intuitive Surgical, Inc. will post 5.22 earnings per share for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.